How to buy Tilray (TLRY) shares in Australia
Learn how to easily invest in Tilray shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Tilray Inc is a drug manufacturers-specialty & generic business with stocks listed in the US. Tilray shares (TLRY) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was US$11 – a decrease of 5.66% over the previous week. Here's how to invest if you're based in Australia.
How to buy shares in Tilray
- Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for Tilray. Find the share by name or ticker symbol: TLRY. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Tilray reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$16.25, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Tilray, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Tilray. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Tilray stock price (NASDAQ:TLRY)Use our graph to track the performance of TLRY stocks over time.
Tilray shares at a glance
|52-week range||US$5.25 - US$55.01|
|50-day moving average||US$11.4909|
|200-day moving average||US$14.9994|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||US$-1.166|
Where to buy Tilray stock
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Tilray stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Considering buying Tilray shares?Before you consider Tilray, you'll want to hear this.
Ticker Nerd uses advanced software to track hundreds of signals and data points to find stocks before they blow up. You can get the next two hot stocks they find sent to your inbox for free.
Show me how
Tilray price performance over time
|3 months (2021-07-26)||-19.71%|
|6 months (2021-04-26)||-38.38%|
|1 year (2020-10-26)||87.71%|
|2 years (2019-10-25)||-53.53%|
|3 years (2018-10-26)||-89.82%|
Is Tilray under- or over-valued?
Valuing Tilray stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Tilray's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Tilray's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$9 million (£0.0 million).
The EBITDA is a measure of a Tilray's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||US$563.6 million|
|Gross profit TTM||US$123.2 million|
|Return on assets TTM||-1.67%|
|Return on equity TTM||-12.02%|
|Market capitalisation||US$5.1 billion|
TTM: trailing 12 months
Shorting Tilray shares
There are currently 38.2 million Tilray shares held short by investors – that's known as Tilray's "short interest". This figure is 1.8% down from 39.0 million last month.
There are a few different ways that this level of interest in shorting Tilray shares can be evaluated.
Tilray's "short interest ratio" (SIR)
Tilray's "short interest ratio" (SIR) is the quantity of Tilray shares currently shorted divided by the average quantity of Tilray shares traded daily (recently around 16.1 million). Tilray's SIR currently stands at 2.37. In other words for every 100,000 Tilray shares traded daily on the market, roughly 2370 shares are currently held short.
However Tilray's short interest can also be evaluated against the total number of Tilray shares, or, against the total number of tradable Tilray shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Tilray's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Tilray shares in existence, roughly 80 shares are currently held short) or 0.0848% of the tradable shares (for every 100,000 tradable Tilray shares, roughly 85 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Tilray.
Find out more about how you can short Tilray stock.
Tilray share dividends
We're not expecting Tilray to pay a dividend over the next 12 months.
Tilray share price volatility
Over the last 12 months, Tilray's shares have ranged in value from as little as US$5.25 up to US$55.01. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tilray's is 2.6198. This would suggest that Tilray's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Tilray, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. The company operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. It provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. The company offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Aphria Inc. Tilray, Inc. was incorporated in 2018 and is based in New York, New York.
Tilray in the news
Curaleaf: Big Cannabis
Tilray Inc. Cl 2 stock outperforms competitors despite losses on the day
Is Canopy Growth Stock A Buy Or Sell Now? Why I'm Getting Bullish
Frequently asked questions
More guides on Finder
How to buy BITO ETF units | $40.58
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Why is the AMP share price looking up today?
Shares in the wealth management giant have been largely stable in the last 6 months.
How to invest in the Judo Capital Holdings IPO
Everything we know about the Judo Capital Holdings IPO, plus information on how to buy in.
How to invest in the Alloggio Group IPO
Everything we know about the Alloggio Group IPO, plus information on how to buy in.
How to invest in the Larvotto Resources IPO
Everything we know about the Larvotto Resources IPO, plus information on how to buy in.
How to invest in the Vulcan Steel IPO
Everything we know about the Vulcan Steel IPO, plus information on how to buy in.
How to invest in the Artrya IPO
Everything we know about the Artrya IPO, plus information on how to buy in.
How to invest in the 8 Au IPO
Everything we know about the 8 Au IPO, plus information on how to buy in.
How to invest in the Radiopharm Theranostics IPO
Everything we know about the Radiopharm Theranostics IPO, plus information on how to buy in.
What has prompted the rebound in the Kogan share price?
The online retailer’s shares have lost more than half their value in the last 12 months.
Ask an Expert